The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
Open accessAbstract
Fibroblasts can be directly reprogrammed into cardiomyocyte‐like cells ( iCM s) by overexpression of cardiac transcription factors or microRNAs. However, induction of functional cardiomyocytes is inefficient, and molecular mechanisms of direct reprogramming remain undefined. Here, we demonstrate that addition of miR‐133a (miR‐133) to Gata4, Mef2c, and Tbx5 (GMT) or GMT plus Mesp1 and Myocd improved cardiac reprogramming from mouse or human fibroblasts by directly repressing Snai1, a master regulator of epithelial‐to‐mesenchymal transition. MiR‐133 overexpression with GMT generated sevenfold more beating iCM s from mouse embryonic fibroblasts and shortened the duration to induce beating cells from 30 to 10 days, compared to GMT alone. Snai1 knockdown suppressed fibroblast genes, upregulated cardiac gene expression, and induced more contracting iCM s with GMT transduction, recapitulating the effects of miR‐133 overexpression. In contrast, overexpression of Snai1 in GMT/miR‐133‐transduced cells maintained fibroblast signatures and inhibited generation of beating iCM s. MiR‐133‐mediated Snai1 repression was also critical for cardiac reprogramming in adult mouse and human cardiac fibroblasts. Thus, silencing fibroblast signatures, mediated by miR‐133/Snai1, is a key molecular roadblock during cardiac reprogramming.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 1×
“…cardiomyocytes, hepatocytes, blood precursor cells, and neural progenitors were successfully induced from fibroblasts by overexpression of lineage-specific transcription factor (Ieda et al, 2010; Szabo et al, 2010; Vierbuchen et al, 2010; Sekiya & Suzuki, 2011; Han et al, 2012; Wada et al, 2013).”
BackgroundDirect reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454 · cited 7×
“Generation of aMHC-GFP and Mesp1-GFP mice Transgenic mice overexpressing GFP under the control of an a-MHC promoter were generated as described previously (Ieda et al, 2010).”
BackgroundMethodResultInfluentialSelf-citationIn vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
MicroRNA-mediated conversion of human fibroblasts to neurons
Yoo, A. S., Sun, A. X., Li, L., Shcheglovitov, A., Portmann, T., Li, Y., Lee-Messer, C., Dolmetsch, R. E., Tsien, R. W., & Crabtree, G. R. (2011) · Nature · doi:10.1038/nature10323 · Cited by 989 · cited 1×
“Yoo et al (2011) reported that a combination of neural-specific miRNAs, miR9/9*, and miR-124, and neurogenic transcription factors directly reprogrammed human fibroblasts into functional neuronal cells (Yoo et al, 2011).”
BackgroundSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
Sekiya, S., & Suzuki, A. (2011) · Nature · doi:10.1038/nature10263 · Cited by 846
Liu, N., Bezprozvannaya, S., Williams, A. H., Qi, X., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Genes & Development · doi:10.1101/gad.1738708 · Cited by 790
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
Jayawardena, T. M., Egemnazarov, B., Finch, E. A., Zhang, L., Payne, J. A., Pandya, K., Zhang, Z., Rosenberg, P., Mirotsou, M., & Dzau, V. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.269035 · Cited by 775
Cited by
Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration
Talman, V., & Ruskoaho, H. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2431-9 · Cited by 905
Direct cell reprogramming: approaches, mechanisms and progress
Wang, H., Yang, Y., Liu, J., & Qian, L. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00335-z · Cited by 444
Therapeutic approaches for cardiac regeneration and repair
Hashimoto, H., Olson, E. N., & Bassel-Duby, R. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0036-6 · Cited by 415
Self-citationCardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies
Liu, M., López de Juan Abad, B., & Cheng, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.021 · Cited by 352
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 332
In Vivo Cellular Reprogramming: The Next Generation
Srivastava, D., & DeWitt, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.055 · Cited by 292
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.03.015 · Cited by 275
Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease
Cui, M., Wang, Z., Bassel-Duby, R., & Olson, E. N. (2018) · Development · doi:10.1242/dev.171983 · Cited by 92
“Although extensive work using both screen-based and genomics-based approaches has identified additional activators, repressors and pathways that can modulate direct cardiac reprogramming, the key to reprogramming appears to be the combinatorial actions of the core cardiac TFs (Abad et al., 2017; Ifkovits et al., 2014;…”
BackgroundChemical compound-based direct reprogramming for future clinical applications.
Takeda, Y., Harada, Y., Yoshikawa, T., & Dai, P. (2018) · Bioscience Reports · doi:10.1042/bsr20171650 · Cited by 57
Canalizing cell fate by transcriptional repression
Lim, B., Domsch, K., Mall, M., & Lohmann, I. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00014-z · Cited by 19
“For example, miR-122 silences the fi broblast TF Snail1, promoting conversion of fi broblasts to cardiomyocytes (Jayawardena et al, 2012; Muraoka et al, 2014).”
BackgroundReprogramming cell fate: a changing story
Chin, M. T. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00046 · Cited by 18
Sano, M., Nakasu, A., Ohtaka, M., & Nakanishi, M. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.10.012 · Cited by 13
Metadata
- Authors
- Muraoka, N., Yamakawa, H., Miyamoto, K., Sadahiro, T., Umei, T., Isomi, M., Nakashima, H., Akiyama, M., Wada, R., Inagawa, K., Nishiyama, T., Kaneda, R., Fukuda, T., Takeda, S., Tohyama, S., Hashimoto, H., Kawamura, Y., Goshima, N., Aeba, R., Yamagishi, H., Fukuda, K., & Ieda, M.
- Venue
- The EMBO Journal
- Published
- 2014-06-11
- Volume
- 33
- Issue
- 14
- Pages
- 1565-1581
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2100172364
- Cited by
- 298
- References
- 28
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.